Power Law company profile

DNAnexus

Biotech & Life Sciences · Mountain View, United States · Founded 2009 Colt

Combines expertise in cloud computing and bioinformatics to create a global network for genomic medicine

Valuation

$500M–1B

Latest valuation · 2026

Unlock exact value

Revenue

$10–50M

Latest reported FY

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

18 investors on DNAnexus's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage

Series B+ 13 investors entered at this stage

Microsoft

Foresite Capital

Innovatus Capital Partners

TPG Biotech

Genuity Science

Perceptive Advisors

Northpond Ventures

Claremont Creek Ventures

Claremont Creek Ventures (CCV)

Blackstone

Midcap Financial

TPG

Global footprint

Where DNAnexus has talent and traffic

AI talent share

1.4% of workforce is AI talent
(4 of 278 staff)

Core AI10.36%

Other AI31.08%

Non-AI workforce27498.56%

Workforce by country

🇺🇸 United States · Mountain View HQ

Book a demo for the full country breakdown

Web traffic by country

150K monthly visits
across markets

🇺🇸 United States49.7%

🇬🇧 United Kingdom13.9%

🇮🇱 Israel8.3%

🇩🇪 Germany6.2%

🇪🇸 Spain3%

Top 5 markets shown

Market sentiment

What the market is saying about DNAnexus

An AI-synthesized read of the highest-engagement posts about DNAnexus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See DNAnexus on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles